IntelGenx Revises Q4 and Full Year 2022 Financial Reporting Date to March 29

26 March 2023 | Sunday | News

IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, announced that, further to its press release of March 23, 2023, it now plans to release its fourth quarter and full year 2022 financial results after market close on Wednesday, March 29, 2023.

An accompanying conference call will be hosted by Dr. Horst G. Zerbe, Chief Executive Officer, and Mr. Andre Godin, President and Chief Financial Officer, to discuss the results and provide a business update. Details of the conference call and webcast are below:

Fourth Quarter and Full Year 2022 Results Conference Call Details:
Date: Wednesday, March 29, 2023
Time: 4:30 p.m. ET
Live Call: 1- 888-506-0062 (Canada and the United States)
  1- 973-528-0011 (International)
Access Code: 884881

The call will also be broadcast live and archived on the Company's website at www.intelgenx.com under "Webcasts" in the Investors section.

 

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close